APA

Brahim L. R., Valete-Rosalino C. M., Antônio L. d. F., Pimentel M. I. F., Lyra M. R., Paes L. E. d. C., Costa A. D. d., Vieira I. F., Dias C. M. G., Duque M. C. d. O., Marzochi M. C. d. A. & Schubach A. d. O. (20171227). Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013). : Memorias do Instituto Oswaldo Cruz.

Chicago

Brahim Lucia Regina, Valete-Rosalino Cláudia Maria, Antônio Liliane de Fátima, Pimentel Maria Inês Fernandes, Lyra Marcelo Rosandiski, Paes Luiz Eduardo de Carvalho, Costa Ananda Dutra da, Vieira Iracema Forni, Dias Cristina Maria Giordano, Duque Maria Cristina de Oliveira, Marzochi Mauro Celio de Almeida and Schubach Armando de Oliveira. 20171227. Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013). : Memorias do Instituto Oswaldo Cruz.

Harvard

Brahim L. R., Valete-Rosalino C. M., Antônio L. d. F., Pimentel M. I. F., Lyra M. R., Paes L. E. d. C., Costa A. D. d., Vieira I. F., Dias C. M. G., Duque M. C. d. O., Marzochi M. C. d. A. and Schubach A. d. O. (20171227). Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013). : Memorias do Instituto Oswaldo Cruz.

MLA

Brahim Lucia Regina, Valete-Rosalino Cláudia Maria, Antônio Liliane de Fátima, Pimentel Maria Inês Fernandes, Lyra Marcelo Rosandiski, Paes Luiz Eduardo de Carvalho, Costa Ananda Dutra da, Vieira Iracema Forni, Dias Cristina Maria Giordano, Duque Maria Cristina de Oliveira, Marzochi Mauro Celio de Almeida and Schubach Armando de Oliveira. Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013). : Memorias do Instituto Oswaldo Cruz. 20171227.